Exploring the Therapeutic Effects of Artemisia rupestris L. Extract on Metabolic Dysfunction-Associated Fatty Liver Disease: Network Pharmacology and In Vitro Experiments

Zheming Xiong, Yijie Su, Luping Shi, Shuyuan Ge, Ge Wang, Fangyu Li, Xu Liu, Jianguang Li, Zejiang Ma · 2026

Read Exploring the Therapeutic Effects of Artemisia rupestris L. Extract on Metabolic Dysfunction-Associated Fatty Liver Disease: Network Pharmacology and In Vitro Experiments by Zheming Xiong, Yijie Su, Luping Shi, Shuyuan Ge, Ge Wang, Fangyu Li, Xu Liu, Jianguang Li, Zejiang Ma (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610929.txt.

Description

Zheming Xiong and co-authors test a plant extract against fatty liver disease in a 2026 study. The plant is Artemisia rupestris, used in traditional medicine for liver protection. Its extract was profiled by liquid chromatography and mass tools, which found seventy-eight compounds, mostly flavonoids and acids. Network methods then linked those compounds to disease targets.

Two targets stood out, and two plant acids were named as key actors. Computer simulations showed one acid binding stably to its target protein. In liver cells loaded with fat, the extract cut stored fats and cholesterol in a dose-based pattern. It shrank fat droplets and lowered two liver harm enzymes, matching a standard drug at the high dose. The authors frame the work as early evidence and a base for animal studies.

Catalog record

CREATORZheming Xiong, Yijie Su, Luping Shi, Shuyuan Ge, Ge Wang, Fangyu Li, Xu Liu, Jianguang Li, Zejiang Ma
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13610929

Browse the full library · About the Tower of Babel